Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Photodynamic therapy was effective in treating multiple scalp basal cell carcinomas with minimal side effects and good cosmetic results.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Platinum-based chemotherapy drugs can cause many severe side effects, often requiring dose reductions and additional medications to manage.

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Low dose oral minoxidil helped treat long-term hair loss caused by chemotherapy in 15 patients.

Cox-2 significantly contributes to the development and progression of skin and esophageal cancers.

Tacalcitol cream effectively and safely treated a rare skin condition called Lichen Spinulosus in two cases.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Imatinib can cause hair loss due to lichen planopilaris.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

Targeting EGFR may help reduce hair loss from chemotherapy.

Topical tacalcitol can treat psoriasis by acting directly on skin cells.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Deep phenotyping helps distinguish between xeroderma pigmentosum and trichothiodystrophy, aiding in diagnosis and treatment.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Mohs micrographic surgery is effective for treating basal cell carcinoma on the eyelid, while radiotherapy has higher recurrence rates, and topical vitamin D3 may reduce and delay BCC formation in mice.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

An 86-year-old man had a rare tongue melanoma but refused treatment, showing the need for early cancer detection and treatment.

Glibenclamide slows breast cancer cell growth by stopping cell division.